News
A wave of menopause-related legislation has been introduced across the United States this year, leading to possible shifts in ...
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...
Master injector Alexander Tirado, who brings unmatched passion and intimate knowledge of multiple disciplines, has been ...
A woman in her 50s takes supplements such as protein powder, fiber, and collagen to build muscle and improve her overall ...
P OOR MENTAL health is a scourge. Prescriptions for anti-depressants and anti-anxiety medicines have soared in rich countries ...
Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology.
8h
GlobalData on MSNPfizer and Astellas’ Xtandi improves OS as combination therapyPfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women ...
T heir names are unknown but their pain is nonetheless evident. A user on Reddit, a social-media site, was “fairly close to ...
10d
News-Medical.Net on MSNStudy links hormone therapy to breast cancer risk in younger womenScientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...
The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results